{ "cik": 1630627, "cik_padded": "0001630627", "entityName": "TREACE MEDICAL CONCEPTS, INC.", "fiscal_years": [ { "accn": "0001193125-26-079167", "filed": "2026-02-27", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 13517000.0, "cash": 10708000.0, "cost_of_revenue": 42938000.0, "eps_diluted": -0.93, "free_cash_flow": -29487000.0, "gross_profit": 169752000.0, "net_income": -59002000.0, "operating_cash_flow": -15970000.0, "operating_income": -54154000.0, "revenue": 212690000.0, "stockholders_equity": 87332000.0, "total_assets": 190581000.0, "total_liabilities": 103249000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.7981193286003103, "leverage": 1.1822585077634773, "net_margin": -0.2774084348112276, "operating_margin": -0.25461469744698856, "revenue_growth_yoy": 0.015920174629938336, "roa_avg2y": -0.28945606181394495, "roa_period_end": -0.3095901480210514, "roe_avg2y": -0.5893599168930798, "roe_period_end": -0.6756057344386938 } }, { "accn": "0001193125-26-079167", "filed": "2026-02-27", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 11593000.0, "cash": 11350000.0, "cost_of_revenue": 41093000.0, "eps_diluted": -0.9, "free_cash_flow": -48760000.0, "gross_profit": 168264000.0, "net_income": -55743000.0, "operating_cash_flow": -37167000.0, "operating_income": -55688000.0, "revenue": 209357000.0, "stockholders_equity": 112892000.0, "total_assets": 217094000.0, "total_liabilities": 104202000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8037180509846816, "leverage": 0.9230237749353364, "net_margin": -0.26625811413040884, "operating_margin": -0.2659954049780996, "revenue_growth_yoy": 0.11885013734648725, "roa_avg2y": -0.23770951447864716, "roa_period_end": -0.25676895722590215, "roe_avg2y": -0.44446836502810666, "roe_period_end": -0.4937728094107643 } }, { "accn": "0001193125-26-079167", "filed": "2026-02-27", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 11458000.0, "cash": 12982000.0, "cost_of_revenue": 35181000.0, "eps_diluted": -0.81, "free_cash_flow": -46033000.0, "gross_profit": 151937000.0, "net_income": -49527000.0, "operating_cash_flow": -34575000.0, "operating_income": -51428000.0, "revenue": 187118000.0, "stockholders_equity": 137938000.0, "total_assets": 251907000.0, "total_liabilities": 113969000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8119849506728375, "leverage": 0.826233525206977, "net_margin": -0.26468324800393334, "operating_margin": -0.274842612682906, "revenue_growth_yoy": 0.3192374398962196, "roa_avg2y": -0.24104776714338905, "roa_period_end": -0.196608272100418, "roe_avg2y": -0.4990955675250797, "roe_period_end": -0.35905261784279896 } }, { "accn": "0001193125-26-079167", "filed": "2026-02-27", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 14838000.0, "cash": 19473000.0, "cost_of_revenue": 25532000.0, "eps_diluted": -0.77, "free_cash_flow": -45486000.0, "gross_profit": 116306000.0, "net_income": -42815000.0, "operating_cash_flow": -30648000.0, "operating_income": -34844000.0, "revenue": 141838000.0, "stockholders_equity": 60529000.0, "total_assets": 159024000.0, "total_liabilities": 98495000.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8199918216556917, "leverage": 1.6272365312494836, "net_margin": -0.301858458241092, "operating_margin": -0.2456605423088312, "revenue_growth_yoy": 0.5022188330738516, "roa_avg2y": -0.2855808834564525, "roa_period_end": -0.26923609014991445, "roe_avg2y": -0.5574797203161417, "roe_period_end": -0.7073468915726346 } }, { "accn": "0000950170-25-029029", "filed": "2025-02-27", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2705000.0, "cash": 105833000.0, "cost_of_revenue": 16888000.0, "eps_diluted": -0.43, "free_cash_flow": -19898000.0, "gross_profit": 77531000.0, "net_income": -20552000.0, "operating_cash_flow": -17193000.0, "operating_income": -16510000.0, "revenue": 94419000.0, "stockholders_equity": 93073000.0, "total_assets": 140821000.0, "total_liabilities": 47748000.0 }, "period_end": "2021-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8211376947436427, "leverage": 0.5130166643387448, "net_margin": -0.21766805409928086, "operating_margin": -0.1748588737436321, "revenue_growth_yoy": 0.645933931839972, "roa_avg2y": -0.2250695402676479, "roa_period_end": -0.14594414185384283, "roe_avg2y": -0.43798015961810993, "roe_period_end": -0.22081591868748188 } }, { "accn": "0000950170-24-021228", "filed": "2024-02-27", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1069000.0, "cash": 18079000.0, "cost_of_revenue": 12470000.0, "eps_diluted": -0.12, "free_cash_flow": -5563000.0, "gross_profit": 44895000.0, "net_income": -3668000.0, "operating_cash_flow": -4494000.0, "operating_income": 855000.0, "revenue": 57365000.0, "stockholders_equity": 776000.0, "total_assets": 41807000.0, "total_liabilities": 41031000.0 }, "period_end": "2020-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.7826200644992591, "leverage": 52.875, "net_margin": -0.06394142769981696, "operating_margin": 0.014904558528719603, "revenue_growth_yoy": 0.4553734524051147, "roa_period_end": -0.08773650345635899, "roe_avg2y": -1.8633477266954535, "roe_period_end": -4.72680412371134 } }, { "accn": "0000950170-23-006603", "filed": "2023-03-08", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD" }, "fundamentals": { "capex": 1211000.0, "cash": 12139000.0, "cost_of_revenue": 7631000.0, "free_cash_flow": -8884000.0, "gross_profit": 31785000.0, "net_income": -4265000.0, "operating_cash_flow": -7673000.0, "operating_income": -3535000.0, "revenue": 39416000.0, "stockholders_equity": 3161000.0 }, "period_end": "2019-12-31", "ratio_units": { "gross_margin": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.8063984168865436, "net_margin": -0.10820478993302213, "operating_margin": -0.08968439212502537, "roe_avg2y": -0.9364364913821496, "roe_period_end": -1.3492565643783612 } }, { "accn": "0000950170-22-002903", "filed": "2022-03-04", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "cash": "USD", "stockholders_equity": "USD" }, "fundamentals": { "cash": 1284000.0, "stockholders_equity": 5948000.0 }, "period_end": "2018-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001193125-26-079167", "filed": "2026-02-27", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "3841", "sic_description": "Surgical & Medical Instruments & Apparatus", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001630627.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001630627.json" }, "ticker": "TMCI" }